Expert Review of Neurotherapeutics

Papers
(The median citation count of Expert Review of Neurotherapeutics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The latest developments in synthetic approaches to Duchenne muscular dystrophy40
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes40
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development32
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis31
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry27
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury27
Current perspectives on the clinical management of cryptogenic stroke26
The latest developments with internet-based psychological treatments for depression26
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis26
An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis25
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection22
Is it possible to prevent relapse in panic disorder?22
Managing cognitive impairment in Parkinson’s disease: an update of the literature22
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications21
Where Art Thou O treatment for diabetic neuropathy: the sequel21
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis20
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options20
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy20
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics20
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain 19
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome19
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?19
Advances in the management of bipolar disorder in children and adolescents: an update on the literature19
Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition19
Current and emerging targeted therapies for spinal muscular atrophy19
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?19
The management of neurofibromatosis type 1 (NF1) in children and adolescents19
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence18
Understanding and managing autonomic dysfunction in persons with multiple sclerosis17
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity17
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management17
Nanomaterials in neuromodulation: what is the potential?17
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper17
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder17
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease17
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis17
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio16
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis15
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions14
Speech and language therapy in primary progressive aphasia: a critical review of current practice14
Therapeutic issues in Guillain–Barré syndrome14
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease14
Spinal cord stimulation for gait disturbances in Parkinson’s disease14
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study13
Status epilepticus in pregnancy: a literature review and a protocol proposal13
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders13
Neurology’s vital role in preventing unnecessary and potentially harmful pediatric studies13
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases13
Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts13
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?12
Central vestibular dysfunction: don’t forget vestibular rehabilitation12
An update on the pharmacotherapeutic options for complex regional pain syndrome12
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men12
Bipolar disorder staging and the impact it has on its management: an update12
An updated review on prediction and preventive treatment of post-stroke depression12
Overcoming clinical challenges of refractory neuropathic pain11
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia11
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date11
Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia11
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions11
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes11
When is pharmacological intervention recommended for adults with social anxiety disorder?10
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis10
Developments in targeting calcitonin gene-related peptide10
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials10
Behavioural Therapy for tic disorders: a comprehensive review of the literature10
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation10
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome10
Correction10
Recent advances in understanding the neurobiology of pediatric functional neurological disorder10
Clinical development of valbenazine for tics associated with Tourette syndrome10
Tumefactive demyelination: updated perspectives on diagnosis and management10
Conventional and emerging treatments and controversies in myasthenia gravis9
Advances in the treatment and management of frontotemporal dementia9
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review9
Outcomes measures in idiopathic intracranial hypertension9
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives9
Gantenerumab for early Alzheimer’s disease: a systematic review and meta-analysis9
The relevance of cortical thickness in migraine sufferers and implications to therapy9
Charcot-Marie-Tooth disease: a review of clinical developments and its management - What’s new in 2025?9
Pharmacological options for narcolepsy: are they the way forward?8
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures8
Emerging strategies and clinical recommendations for the management of novel depression subtypes8
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias8
Challenges in the treatment of dysthymia: a narrative review8
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent8
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy8
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression8
Emerging role of artificial intelligence in stroke imaging8
Long-term central nervous system (CNS) consequences of COVID-19 in children8
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy8
Telerehabilitation in neurorehabilitation: has it passed the COVID test?8
Personal narratives and the pursuit of purpose and possibility in psychosis: directions for developing recovery-oriented treatments7
An update on combination therapies for multiple sclerosis: where are we now?7
Role of environmental factors in multiple sclerosis7
The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer’s disease: a critical review7
Insights into headache 20227
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead7
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions7
The early recognition and diagnosis of neoplastic meningitis7
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations7
Seizure medication and planned pregnancy: balancing the risks and outcomes7
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review7
Updated review on the link between cortical spreading depression and headache disorders7
Impact of psychiatric comorbidities on the treatment of epilepsies in adults7
Recent advancements in tension-type headache: a narrative review7
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper7
Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy7
Suicidality and antiepileptic drugs in people with epilepsy: an update7
Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: a pragmatic review6
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?6
The latest advances in the pharmacological management of focal epilepsies in children: a narrative review6
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints6
Imaging of congenital and developmental cystic lesions of the brain: a narrative review6
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials6
Why is ADHD so difficult to diagnose in older adults?6
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression6
Neurosarcoidosis: an update on diagnosis and therapy6
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia6
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review6
Updated strategies for the management of poor medication adherence in patients with bipolar disorder6
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monothera6
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies6
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy5
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents5
The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications5
The impact of exercise on Alzheimer’s disease progression5
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies5
An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention5
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?5
Meniere disease subtyping: the direction of diagnosis and treatment in the future5
Novel techniques for early diagnosis and monitoring of Alzheimer’s disease5
Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials5
The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature5
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease5
Treatment options for post-traumatic epilepsy: an update on clinical and translational aspects5
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review5
Orexins and primary headaches: an overview of the neurobiology and clinical impact5
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment5
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions5
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder5
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?4
Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?4
A review of magnetoencephalography use in pediatric epilepsy: an update on best practice4
Acute and long-term cognitive impairment following sepsis: mechanism and prevention4
Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?4
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder4
Advances in amyloid-targeting monoclonal antibodies for Alzheimer’s disease: clinical and public health issues4
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis4
Non-pharmacological treatments for pediatric refractory epilepsies4
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis4
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?4
Temporal distribution of emergency room visits in patients with migraine and other headaches4
Thalamic neuromodulation in epilepsy: A primer for emerging circuit-based therapies4
MR-guided high-intensity focused ultrasound for chronic pain: where do we stand?4
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan4
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms4
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder4
Learnings in developmental and epileptic encephalopathies: what do we know?4
Pain in cervical dystonia: mechanisms, assessment and treatment4
Managing sleep issues in Parkinson’s disease: an up-to-date review4
Rethinking the role of trazodone in the different depressive dimensions4
Preventing recurrence of postpartum depression by regulating sleep4
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults4
What are the considerations when initiating treatment for epilepsy in children?4
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder4
Deep brain stimulation: new programming algorithms and teleprogramming4
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders3
Beyond pain catastrophizing: rationale and recommendations for targeting trauma in the assessment and treatment of chronic pain3
Is internet-based psychological therapy effective for treating major depressive disorder?3
Hesitancies in primary headaches treatments3
Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer’s disease3
The management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): an update of the literature3
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis3
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence3
Correction3
Postoperative pain: a review of emerging therapeutic options3
The potential of cell therapies for cerebral palsy: where are we today?3
Viruses - a major cause of amyloid deposition in the brain3
Are pharmacotherapeutics effective for treating aphasia?3
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease3
Selecting the right treatment plan for schizophrenia in postmenopausal women: an update of the literature3
Sacroiliac joint pain: what treatment and when3
Monitoring risk and preventing ischemic stroke in the very old3
Risk of suicide and suicide-related events in subjects treated with antiseizure medications3
Correction3
Clinical applications of exercise in Parkinson’s disease: what we need to know?3
Current challenges in primary lateral sclerosis diagnosis3
Intranasal zavegepant for the acute treatment of migraine3
Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation3
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?3
Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam3
Mindfulness as a therapeutic option for obsessive-compulsive disorder3
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension3
The risks versus the benefits of pharmacological intervention in social anxiety disorder in children3
Correction3
Therapeutic barriers for headache management: issues facing the global north and global south in 20243
Identifying risk factors for chronic postsurgical pain and preventive measures: a comprehensive update2
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?2
Current and emerging treatment modalities for spinocerebellar ataxias2
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond2
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis2
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses2
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant2
The value of hypothermia as a neuroprotective and antiepileptic strategy in patients with status epilepticus: an update of the literature2
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience2
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound2
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature2
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review2
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia2
Pharmacological management of gambling disorder: an update of the literature2
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study2
Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features2
Magnetic resonance-guided focused ultrasound for the treatment of tremor2
Hormonal therapies in migraine management: current perspectives on patient selection and risk management2
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis2
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine2
The role of a potential biomarker in patients with migraine: review and new insights2
Using pharmacotherapy to address sleep disturbances in autism spectrum disorders2
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts2
Sydenham’s chorea: from pathophysiology to therapeutics2
Advances in the early diagnosis of amyotrophic lateral sclerosis2
Focal cortical dysplasia: an update on diagnosis and treatment2
Spinal automaticity of movement control and its role in recovering function after spinal injury2
Deep brain stimulation and stereotactic-assisted brain graft injection targeting fronto-striatal circuits for Huntington’s disease: an update2
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis2
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment2
Can regular physical exercise be a treatment for panic disorder? A systematic review2
An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET2
What is the role of placebo in neurotherapeutics?2
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?2
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis2
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients2
A critical review of oliceridine injection as an IV opioid analgesic for the management of severe acute pain2
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies2
0.26033115386963